Stocks and Investing Stocks and Investing
Mon, October 2, 2023
[ 12:00 AM ] - WOPRAI
Joon Lee Reiterated (ARGX) at Strong Buy and Held Target at $570 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Devin McDermott Maintained (AR) at Hold with Increased Target to $25 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Brian Nowak Reiterated (AMZN) at Buy and Held Target at $175 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Ryan Nash Downgraded (BFH) to Strong Sell and Held Target at $32 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
John Edwards Maintained (BHF) at Hold with Decreased Target to $50 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Bryan Blair Reiterated (ZWS) at Buy and Held Target at $33 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Rob Owens Upgraded (ZS) to Buy and Increased Target to $190 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Maintained (ZBH) at Hold with Decreased Target to $125 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Ryan MacDonald Reiterated (ZETA) at Strong Buy and Held Target at $13 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Joshua Reilly Maintained (ZI) at Strong Buy with Decreased Target to $25 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Shaul Eyal Initiated (BBAI) at Hold and Held Target at $2 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Michael Hoffman Reiterated (WCN) at Strong Buy and Held Target at $168 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Devin McDermott Maintained (XOM) at Buy with Increased Target to $134 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (XPO) at Hold with Increased Target to $68 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Scott Davis Upgraded (XYL) to Strong Buy and Held Target at $122 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Carlos De Alba Upgraded (X) to Buy and Held Target at $40 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
RJ Milligan Maintained (WPC) at Buy with Decreased Target to $63 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Sean McGowan Reiterated (CELH) at Strong Buy and Held Target at $73 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Christopher Stathoulopoulos Maintained (CCL) at Buy with Decreased Target to $16 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Steven Wieczynski Maintained (CCL) at Strong Buy with Decreased Target to $20 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Patrick Scholes Reiterated (CCL) at Hold and Held Target at $17 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Sharon Zackfia Initiated (CCL) at Buy on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
John Baumgartner Initiated (STKL) at Strong Buy and Held Target at $9 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Bernie McTernan Reiterated (SSTK) at Strong Buy and Held Target at $76 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Thornton Reiterated (SPOT) at Strong Buy and Held Target at $170 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Edward White Reiterated (SNDX) at Strong Buy with Increased Target to $42 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (SNCY) at Hold with Decreased Target to $25 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Dan Dolev Downgraded (TOST) to Hold and Decreased Target to $16 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Matthew Taylor Maintained (TNDM) at Strong Buy with Decreased Target to $45 on, Oct 2nd, 2023
[ 12:00 AM ] - WOPRAI
Joanne Wuensch Maintained (TNDM) at Hold with Decreased Target to $23 on, Oct 2nd, 2023

Joanne Wuensch Maintained (TNDM) at Hold with Decreased Target to $23 on, Oct 2nd, 2023


Published on 2024-10-28 06:39:41 - WOPRAI, Joanne Wuensch
  Print publication without navigation


Joanne Wuensch of Citigroup, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Hold with Decreased Target from $31 to $23 on, Oct 2nd, 2023.

Joanne has made no other calls on TNDM in the last 4 months.



There are 5 other peers that have a rating on TNDM. Out of the 5 peers that are also analyzing TNDM, 2 agree with Joanne's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Jeff Johnson of "Baird" Maintained at Hold with Decreased Target to $32 on, Monday, August 21st, 2023
  • Larry Biegelsen of "Wells Fargo" Maintained at Hold with Decreased Target to $30 on, Friday, August 4th, 2023


These are the ratings of the 3 analyists that currently disagree with Joanne

  • Matt Miksic of "Barclays" Maintained at Buy with Decreased Target to $62 on, Monday, August 7th, 2023
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $34 on, Friday, August 4th, 2023
  • Alexander Nowak of "Craig-Hallum" Maintained at Strong Buy with Decreased Target to $50 on, Tuesday, June 13th, 2023
Contributing Sources